Patients with TBK1 mutations have been described with the clinical syndrome of FTD (usually the behavioral variant), MND (usually amyotrophic lateral sclerosis), or the combination of both [6], but few details are currently known about the clinical phenotype, atrophy pattern, and time-course of the disease. This evidence concerns the gene TBK1 and frontotemporal dementia.